应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GPCR STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD
休市中 02-14 16:00:00 EST
24.39
+0.02
+0.08%
盘后
24.90
+0.51
+2.09%
19:56 EST
最高
25.17
最低
24.23
成交量
43.15万
今开
24.48
昨收
24.37
日振幅
3.87%
总市值
13.97亿
流通市值
12.49亿
总股本
5,726万
成交额
1,062万
换手率
0.84%
流通股本
5,121万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
硕迪生物盘中异动 早盘股价大跌5.11%报26.00美元
市场透视 · 02-10
硕迪生物盘中异动 早盘股价大跌5.11%报26.00美元
硕迪生物盘中异动 下午盘大幅下挫5.06%报28.50美元
市场透视 · 02-07
硕迪生物盘中异动 下午盘大幅下挫5.06%报28.50美元
硕迪生物盘中异动 早盘股价大涨5.01%
市场透视 · 02-04
硕迪生物盘中异动 早盘股价大涨5.01%
硕迪生物盘中异动 临近收盘快速下挫5.11%报28.44美元
市场透视 · 02-03
硕迪生物盘中异动 临近收盘快速下挫5.11%报28.44美元
硕迪生物盘中异动 早盘大幅上涨5.02%报30.15美元
市场透视 · 01-29
硕迪生物盘中异动 早盘大幅上涨5.02%报30.15美元
硕迪生物盘中异动 临近午盘股价大涨5.36%报28.51美元
市场透视 · 01-21
硕迪生物盘中异动 临近午盘股价大涨5.36%报28.51美元
硕迪生物盘中异动 早盘股价大涨5.28%报26.72美元
市场透视 · 01-15
硕迪生物盘中异动 早盘股价大涨5.28%报26.72美元
硕迪生物盘中异动 早盘股价大跌5.82%
市场透视 · 01-13
硕迪生物盘中异动 早盘股价大跌5.82%
硕迪生物盘中异动 大幅下挫5.18%
市场透视 · 01-10
硕迪生物盘中异动 大幅下挫5.18%
BUZZ-生物技术年末充满 "曲线球",将出现小幅下跌
路透中文 · 2024-12-31
BUZZ-生物技术年末充满 "曲线球",将出现小幅下跌
BUZZ-对于肥胖症药物开发商来说,维京人将在 "充满挑战 "的一年里翻一番
路透中文 · 2024-12-31
BUZZ-对于肥胖症药物开发商来说,维京人将在 "充满挑战 "的一年里翻一番
硕迪生物盘中异动 早盘股价大跌5.28%
市场透视 · 2024-12-30
硕迪生物盘中异动 早盘股价大跌5.28%
硕迪生物盘中异动 大幅上涨5.13%报29.70美元
市场透视 · 2024-12-26
硕迪生物盘中异动 大幅上涨5.13%报29.70美元
硕迪生物盘中异动 急速下跌5.26%
市场透视 · 2024-12-20
硕迪生物盘中异动 急速下跌5.26%
BUZZ--美国股票走势-Spire、铜矿商、Abercrombie & Fitch
Reuters · 2024-12-20
BUZZ--美国股票走势-Spire、铜矿商、Abercrombie & Fitch
BUZZ--美国股票走势-Mission Produce、Sirius XM、嘉年华公司
Reuters · 2024-12-20
BUZZ--美国股票走势-Mission Produce、Sirius XM、嘉年华公司
背景资料-减肥药开发商排队开发价值 1500 亿美元的市场
Reuters · 2024-12-20
背景资料-减肥药开发商排队开发价值 1500 亿美元的市场
BUZZ--美国股票走势-Humacyte、Ionis 制药公司、Emeren 集团
路透中文 · 2024-12-20
BUZZ--美国股票走势-Humacyte、Ionis 制药公司、Emeren 集团
BUZZ--美国股票走势-联邦快递、礼来公司、Aadi 生物科学公司
Reuters · 2024-12-20
BUZZ--美国股票走势-联邦快递、礼来公司、Aadi 生物科学公司
BUZZ-诺和诺德肥胖症药物在研究中表现不佳,减肥药开发商获益匪浅
Reuters · 2024-12-20
BUZZ-诺和诺德肥胖症药物在研究中表现不佳,减肥药开发商获益匪浅
加载更多
公司概况
公司名称:
STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD
所属市场:
NASDAQ
上市日期:
--
主营业务:
硕迪生物公司于2019年2月在开曼群岛成立,在美国和中国设有运营子公司。该公司是一家临床阶段的全球生物制药公司,旨在开发和提供新型口服疗法,以治疗各种慢性疾病,满足医疗需求。公司的差异化技术平台利用基于结构的药物发现和计算化学专业知识,使公司能够开发口服小分子疗法,用于治疗各种疾病,包括影响代谢、心血管和肺系统的疾病。
发行价格:
--
{"stockData":{"symbol":"GPCR","market":"US","secType":"STK","nameCN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","latestPrice":24.39,"timestamp":1739566800000,"preClose":24.37,"halted":0,"volume":431473,"hourTrading":{"tag":"盘后","latestPrice":24.9,"preClose":24.39,"latestTime":"19:56 EST","volume":18103,"amount":446422.65,"timestamp":1739581004545},"delay":0,"floatShares":51207697,"shares":57260672,"eps":-2.215678,"marketStatus":"休市中","change":0.02,"latestTime":"02-14 16:00:00 EST","open":24.48,"high":25.1723,"low":24.23,"amount":10618798.626975,"amplitude":0.038666,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.215678,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1739869200000},"marketStatusCode":7,"adr":0,"adrRate":3,"listingDate":1675400400000,"exchange":"NASDAQ","adjPreClose":24.37,"preHourTrading":{"tag":"盘前","latestPrice":24.45,"preClose":24.37,"latestTime":"09:18 EST","volume":9857,"amount":242116.20959,"timestamp":1739542723765},"postHourTrading":{"tag":"盘后","latestPrice":24.9,"preClose":24.39,"latestTime":"19:56 EST","volume":18103,"amount":446422.65,"timestamp":1739581004545},"volumeRatio":0.4798091674848826,"impliedVol":0.7155,"impliedVolPercentile":0.0876},"requestUrl":"/m/hq/s/GPCR","defaultTab":"news","newsList":[{"id":"2510632448","title":"硕迪生物盘中异动 早盘股价大跌5.11%报26.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510632448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510632448?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:41","pubTimestamp":1739198462,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时41分,硕迪生物股票出现异动,股价快速下跌5.11%。截至发稿,该股报26.00美元/股,成交量2.7629万股,换手率0.05%,振幅4.71%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-34.26百万美元,每股收益-0.60美元,毛利-267175.50美元,市盈率-12.11倍。机构评级方面,在所有11家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体涨幅为0.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021022410298807a1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021022410298807a1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2509288720","title":"硕迪生物盘中异动 下午盘大幅下挫5.06%报28.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509288720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509288720?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:59","pubTimestamp":1738954773,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日02时59分,硕迪生物股票出现异动,股价急速下跌5.06%。截至发稿,该股报28.50美元/股,成交量54.9113万股,换手率0.96%,振幅6.30%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-34.26百万美元,每股收益-0.60美元,毛利-267175.50美元,市盈率-13.27倍。机构评级方面,在所有11家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体跌幅为0.70%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208025933a23d5a5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208025933a23d5a5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2508680564","title":"硕迪生物盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508680564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508680564?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:16","pubTimestamp":1738682202,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时16分,硕迪生物股票出现波动,股价大幅拉升5.01%。截至发稿,该股报29.77美元/股,成交量4.8397万股,换手率0.08%,振幅4.53%。机构评级方面,在所有11家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体涨幅为1.24%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204231643a23931fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204231643a23931fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4599","GPCR"],"gpt_icon":0},{"id":"2508897178","title":"硕迪生物盘中异动 临近收盘快速下挫5.11%报28.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508897178","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508897178?lang=zh_cn&edition=full","pubTime":"2025-02-04 04:52","pubTimestamp":1738615938,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日04时52分,硕迪生物股票出现波动,股价快速下挫5.11%。截至发稿,该股报28.44美元/股,成交量40.5774万股,换手率0.71%,振幅4.00%。机构评级方面,在所有11家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体跌幅为0.25%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204045218a23854c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204045218a23854c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2507563228","title":"硕迪生物盘中异动 早盘大幅上涨5.02%报30.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507563228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507563228?lang=zh_cn&edition=full","pubTime":"2025-01-29 23:22","pubTimestamp":1738164154,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日23时22分,硕迪生物股票出现波动,股价快速拉升5.02%。截至发稿,该股报30.15美元/股,成交量33.002万股,换手率0.58%,振幅4.73%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-34.26百万美元,每股收益-0.60美元,毛利-267175.50美元,市盈率-13.93倍。机构评级方面,在所有11家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体涨幅为0.52%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129232234abbc64dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129232234abbc64dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4599","BK4007"],"gpt_icon":0},{"id":"2505096592","title":"硕迪生物盘中异动 临近午盘股价大涨5.36%报28.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505096592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505096592?lang=zh_cn&edition=full","pubTime":"2025-01-22 00:59","pubTimestamp":1737478795,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日00时59分,硕迪生物股票出现波动,股价大幅上涨5.36%。截至发稿,该股报28.51美元/股,成交量18.857万股,换手率0.33%,振幅5.82%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-34.26百万美元,每股收益-0.60美元,毛利-267175.50美元,市盈率-13.13倍。机构评级方面,在所有11家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体涨幅为1.77%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122005955abb366c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122005955abb366c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2503640879","title":"硕迪生物盘中异动 早盘股价大涨5.28%报26.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503640879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503640879?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951525,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分,硕迪生物股票出现波动,股价快速拉升5.28%。截至发稿,该股报26.72美元/股,成交量1.2386万股,换手率0.02%,振幅1.58%。机构评级方面,在所有11家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体涨幅为0.77%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223205ababf250&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223205ababf250&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2503402583","title":"硕迪生物盘中异动 早盘股价大跌5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503402583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503402583?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:34","pubTimestamp":1736778872,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时34分,硕迪生物股票出现波动,股价快速下跌5.82%。截至发稿,该股报23.79美元/股,成交量2.9926万股,换手率0.05%,振幅4.93%。机构评级方面,在所有11家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体跌幅为0.99%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132234339864d64f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132234339864d64f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4007","GPCR"],"gpt_icon":0},{"id":"2502904897","title":"硕迪生物盘中异动 大幅下挫5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502904897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502904897?lang=zh_cn&edition=full","pubTime":"2025-01-11 01:13","pubTimestamp":1736529235,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日01时13分,硕迪生物股票出现波动,股价快速跳水5.18%。截至发稿,该股报25.64美元/股,成交量33.4952万股,换手率0.58%,振幅4.62%。机构评级方面,在所有11家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体跌幅为2.09%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011101135595ff8e3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011101135595ff8e3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4599","GPCR"],"gpt_icon":0},{"id":"2500645237","title":"BUZZ-生物技术年末充满 \"曲线球\",将出现小幅下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2500645237","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500645237?lang=zh_cn&edition=full","pubTime":"2025-01-01 02:26","pubTimestamp":1735669596,"startTime":"0","endTime":"0","summary":"BUZZ-生物技术年末充满 \"曲线球\",将出现小幅下跌12月31日 - ** 纳斯达克生物技术指数.NBI在2023年上涨4%之后,今年有望下跌2%。** 加拿大皇家银行分析师称,\"意料之外 \"是生物技术公司2024年的主题,一连串非传统的医疗保健领导层提名将给该行业带来另一个 \"曲线球\"。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241231:nL4S3NW0OZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XBI","BK4581","MRUS","LU0320765992.SGD","BK4588","GPCR","VRDN","BK4585","LU0889565916.HKD","BK4007","BK4599","LU0109394709.USD"],"gpt_icon":0},{"id":"2500610398","title":"BUZZ-对于肥胖症药物开发商来说,维京人将在 \"充满挑战 \"的一年里翻一番","url":"https://stock-news.laohu8.com/highlight/detail?id=2500610398","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500610398?lang=zh_cn&edition=full","pubTime":"2025-01-01 00:58","pubTimestamp":1735664325,"startTime":"0","endTime":"0","summary":"12月31日 - ** Viking Therapeutics VKTX.O的股价今年上涨了一倍多,有望连续 第三年上涨 ** 其他较小的肥胖症药物开发商,如 Structure Therapeutics GPCR.O、Altimmune >和 Amgen AMGN.O的股价将在今年年底出现亏损 。** BMO Capital的分析师称2024年是 \"肥胖症交易充满挑战的一年\"--因为投资者之前通过投资VKTX、GPCR和ALT等 进入减肥领域的公司获得了 可观的回报。** 券商称,尽管 肥胖症仍是一个 \"巨大的 \"长期收入机会,但投资者已变得更加挑剔,并将重点放在 \"明显差异化 \"的产品上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241231:nL4T3NW0NG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU1878469433.USD","ALT","LU0122379950.USD","BK4585","LU1571399168.USD","IE00B2B36J28.USD","LU1983299246.USD","BK4534","BK4566","LU1057294990.SGD","LU0320765992.SGD","LU1061106388.HKD","IE00B4R5TH58.HKD","BK4599","IE00BJT1NW94.SGD","GPCR","IE0002141913.USD","LU1023059063.AUD","IE0009355771.USD","BK4007","BK4533","AMGN","VKTX","BK4588","IE00BFTCPJ56.SGD","LU0868494617.USD","LU2242652126.USD","LU2112291526.USD","BK4139","BK4581","LU2242646821.SGD","SG9999001440.SGD","LU0889565916.HKD","LU0109394709.USD","LU0058720904.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2495052977","title":"硕迪生物盘中异动 早盘股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495052977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495052977?lang=zh_cn&edition=full","pubTime":"2024-12-30 23:21","pubTimestamp":1735572070,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日23时21分,硕迪生物股票出现异动,股价大幅下跌5.28%。截至发稿,该股报27.51美元/股,成交量4.5384万股,换手率0.08%,振幅4.11%。机构评级方面,在所有11家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体跌幅为1.15%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123023211095f2cefa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123023211095f2cefa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","GPCR","BK4007"],"gpt_icon":0},{"id":"2494861108","title":"硕迪生物盘中异动 大幅上涨5.13%报29.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494861108","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494861108?lang=zh_cn&edition=full","pubTime":"2024-12-26 23:17","pubTimestamp":1735226237,"startTime":"0","endTime":"0","summary":"北京时间2024年12月26日23时17分,硕迪生物股票出现异动,股价快速拉升5.13%。截至发稿,该股报29.70美元/股,成交量4.9674万股,换手率0.09%,振幅5.70%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-34.26百万美元,每股收益-0.60美元,毛利-267175.50美元,市盈率-13.66倍。机构评级方面,在所有11家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体跌幅为0.14%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122623171798504e95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122623171798504e95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4599","BK4007"],"gpt_icon":0},{"id":"2493564478","title":"硕迪生物盘中异动 急速下跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493564478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493564478?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:53","pubTimestamp":1734720785,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日02时53分,硕迪生物股票出现异动,股价急速跳水5.26%。机构评级方面,在所有11家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体涨幅为0.52%。硕迪生物公司简介:硕迪生物技术有限公司是一家临床阶段的生物制药公司,旨在开发和提供新型口服治疗药物,以治疗多种未满足医疗需求的慢性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221025306ab87ce50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221025306ab87ce50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2493270934","title":"BUZZ--美国股票走势-Spire、铜矿商、Abercrombie & Fitch","url":"https://stock-news.laohu8.com/highlight/detail?id=2493270934","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493270934?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:41","pubTimestamp":1734720117,"startTime":"0","endTime":"0","summary":" * 个股走势的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * 新闻早报通讯: 12月20日 - 华尔街主要股指周五在震荡交投中跳涨,原因是一份冷于预期的通胀报告缓解了美联储预测2025年仅两次降息引发的一些市场担忧。美国东部时间13:30,道琼斯工业平均指数 上涨1.47%,报42963.15点;标普500指数 上涨1.36%,报5947.02点;纳斯达克综合指数 上涨1.34%,报19632.11点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QID","USJW.SI","FCX","NEM","SQQQ","SR","FDX","HUMA","SNPS","DJX","DOG",".SPX","IONS","GPCR","ISSC","TSYW.SI","SDOW","AMGN","CCL","APLM","KMX","SCCO","TQQQ","NQmain","AVO","NVIW.SI","MRK","LU1037948897.HKD","DDM","SOL","X","QLD","LU0719512351.SGD","GALT","SIRI","ALT",".IXIC",".DJI","DXD","MNQmain","PSQ","WGO","VKTX","AADI","USAW.SI","LU1934455194.USD"],"gpt_icon":1},{"id":"2492440770","title":"BUZZ--美国股票走势-Mission Produce、Sirius XM、嘉年华公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492440770","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492440770?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:39","pubTimestamp":1734709181,"startTime":"0","endTime":"0","summary":" * 个股走势的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 12月20日 - 标普500指数和纳斯达克指数周五下跌,原因是市场担心明年的高利率问题,尽管一份冷于预期的通胀报告抑制了损失。美国东部时间10:30,道琼斯工业平均指数 上涨0.61%,报42601.62点。标普500指数 上涨0.49%,报5895.94点;纳斯达克综合指数 上涨0.44%,报19457.30点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".SPX","CCL",".IXIC","TSYW.SI","GALT","KMX","AMGN","SQQQ","APLM","NQmain","ALT","WGO",".DJI","USJW.SI","KUKE","QID","DXD","GPCR","IONS","SOL","XM","AVO","LLY","PSQ","X","MNQmain","CLW","SIRI","FDX","TQQQ","DDM","NVO","DJX","QLD","AADI","VNCE","MRK","FDS","SDOW","NVIW.SI","DNMR","IIPR","USAW.SI","VKTX","HUMA","DOG","SNPS"],"gpt_icon":1},{"id":"2492544239","title":"背景资料-减肥药开发商排队开发价值 1500 亿美元的市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2492544239","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492544239?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:59","pubTimestamp":1734706761,"startTime":"0","endTime":"0","summary":"与Wegovy试验68周后体重减轻约15%相比, 。11 月,该公司称,在一项早期试验中,该药物帮助 9 名接受最高 100 毫克剂量治疗的患者在 28 天后平均减轻了 8.2% 的体重。该公司在 8 月份表示,它将在今年下半年开始与其他制药公司洽谈开发和商业化 petrelintide 的潜在合作事宜。Zealand 公司目前正在进行一项中期研究,在没有 2 型糖尿病的超重或肥胖患者中测试 petrelintide。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","LU0466842654.USD","LU1037948897.HKD","LU2361045086.USD","SGXZ99366536.SGD","LU2461242641.AUD","IE00B2B36J28.USD","LU1093756325.SGD","LU0122379950.USD","LU0965509010.AUD","IE00BJLML261.HKD","LU1868837300.USD","LU2491050071.SGD","LU2089984988.USD","LU1917777945.USD","LU0097036916.USD","NVO","IE00B1BXHZ80.USD","LU0079474960.USD","SG9999015945.SGD","LU1989772923.USD","GPCR","LU0861579265.USD","LU1868836757.USD","SG9999002224.SGD","LU0471298777.SGD","LU2242652126.USD","LU0354030511.USD","OPK","LU1941712348.USD","PFE","BK4534","LU2602419157.SGD","LU0203202063.USD","SG9999018865.SGD","IE00BJT1NW94.SGD","LU2361044865.SGD","SGXZ57979304.SGD","IE000M9KFDE8.USD","IE00BK4W5M84.HKD","LU2211815571.USD","SG9999018857.SGD","LU0203201768.USD","MRK","LU2237443382.USD","LU1983299246.USD","LU0708995401.HKD","IE0002141913.USD","LLY","AMGN"],"gpt_icon":1},{"id":"2492449584","title":"BUZZ--美国股票走势-Humacyte、Ionis 制药公司、Emeren 集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2492449584","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492449584?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:12","pubTimestamp":1734703974,"startTime":"0","endTime":"0","summary":"** 联邦快递FDX.N:BUZZ - 分析师认为联邦快递分拆货运部门是有益的;将PT升至 nL4N3NL0I5 。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nL4T3NL0VS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IONS","SG9999015986.USD","BK4133","LU0157215616.USD","LU2458330243.SGD","FDX","LU0957791311.USD","VKTX","LU0823416689.USD","KMX","SNPS","AMPS","LU1914381329.SGD","BK4555","GALT","LU0096364046.USD","LU0114720955.EUR","LU0256863902.USD","LU0348723411.USD","LU0094547139.USD","LU2458330169.SGD","IE00BJLML261.HKD","LU2357305700.SGD","ALT","LU2238339852.HKD","LU1988902786.USD","SGXZ81514606.USD","LU1280957306.USD","WGO","APLM","LU0310800965.SGD","LU1878469433.USD","AADI","ANSS","LU2361044949.HKD","SOL","TSYW.SI","LU0061475181.USD","LLY","GPCR","X","IE00B4R5TH58.HKD","HUMA","AMGN","LU0466842654.USD","LU0109392836.USD","SG9999015978.USD","LU0820561818.USD","LU1429558221.USD"],"gpt_icon":1},{"id":"2492414611","title":"BUZZ--美国股票走势-联邦快递、礼来公司、Aadi 生物科学公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492414611","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492414611?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:04","pubTimestamp":1734696255,"startTime":"0","endTime":"0","summary":"** 联邦快递 : BUZZ - 分析师认为联邦快递分拆货运卡车部门是有益的;上调PT ** Eli Lilly and Co : BUZZ - 诺和诺德的下一代肥胖症药物在研究中表现不佳,导致价格上涨 ** Humacyte : BUZZ - 因血管植入物获得 FDA 批准而上涨逾 40 ** 美国钢铁 : BUZZ - 在预测第四季度意外亏损后下跌 ** Aadi Bioscience : BUZZ - 因癌症药物许可协议而上涨 ** Viking Therapeutics :** Structure Therapeutics :** Altimmune :** 安进 : BUZZ - 诺和诺德的肥胖症药物在研究中表现不佳,减肥药开发商获得收益 ** Ionis Pharmaceuticals : BUZZ - 因FDA批准遗传性疾病药物而上涨","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131342.USD","GPCR","LU0354030511.USD","LU0289739699.SGD","FDX","BK4585","LU2089984988.USD","LU2360106947.USD","LU1551013425.SGD","HUMA","LU0122379950.USD","LU1988902786.USD","LU0882574139.USD","LU1035775433.USD","LU0320765992.SGD","LU0310800965.SGD","LLY","LU1061106388.HKD","LU1868837300.USD","LU0079474960.USD","ALT","LU1814569148.SGD","BK4520","SG9999018857.SGD","LU0742534661.SGD","LU0354030438.USD","LU0238689110.USD","LU1868836591.USD","IE00B4R5TH58.HKD","LU2265009873.SGD","IONS","BK4588","LU1093756325.SGD","SG9999001440.SGD","IE00BJT1NW94.SGD","SG9999017495.SGD","BK4599","LU2602419157.SGD","LU0471298694.HKD","BK4006","LU0114720955.EUR","AADI","AMGN","LU0058720904.USD","LU0820561909.HKD","X","LU1878469433.USD","VKTX","IE00B1BXHZ80.USD","LU0466842654.USD"],"gpt_icon":1},{"id":"2492241903","title":"BUZZ-诺和诺德肥胖症药物在研究中表现不佳,减肥药开发商获益匪浅","url":"https://stock-news.laohu8.com/highlight/detail?id=2492241903","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492241903?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:40","pubTimestamp":1734694859,"startTime":"0","endTime":"0","summary":" 12月20日 - ** 诺和诺德公司的 下一代肥胖症实验药物在后期试验中的减重效果低于预期,一些减肥药开发商的股票在盘前上涨** 诺和诺德称其药物CagriSema帮助超重患者减轻了22.7%的体重 ,低于其25%的预期。** 诺和诺德在美国上市的股票下跌 22.4%,而竞争对手礼来 上涨 10** 投资者和分析师热切期待着这一数据,以检验诺和诺德是否拥有强大的药物管线,在竞争激烈的抗肥胖症市场上紧随Wegovy之后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640476718.USD","LU1093756168.USD","LU1878469433.USD","LU2491050154.USD","LU0471298777.SGD","VKTX","SG9999014898.SGD","GPCR","IE00BZ1G4Q59.USD","LU0320765059.SGD","LU0096364046.USD","LU1623119135.USD","LU0385154629.USD","LU0820561909.HKD","LU1804176565.USD","LU0820561818.USD","LU1814569148.SGD","IE00BK4W5M84.HKD","LU0943347566.SGD","IE00BKVL7J92.USD","LU1551013342.USD","LU0198837287.USD","IE00BJT1NW94.SGD","LU2237443978.SGD","LU2461242641.AUD","LU2264538146.SGD","NVO","LU0882574139.USD","AMGN","LU0689472784.USD","LU2237438978.USD","IE00BJJMRZ35.SGD","LU1291159041.SGD","LU2361044865.SGD","SG9999001176.SGD","LLY","LU2242652126.USD","LU0109391861.USD","LU1868836757.USD","LU0354030438.USD","ALT","LU0256863811.USD","LU2089984988.USD","LU1571399168.USD","SG9999014906.USD","LU1712237335.SGD","SGXZ57979304.SGD","LU1983299246.USD","LU0203202063.USD","LU1868836914.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.structuretx.com","stockEarnings":[{"period":"1week","weight":-0.1099},{"period":"1month","weight":-0.093},{"period":"3month","weight":-0.2862},{"period":"6month","weight":-0.3429},{"period":"1year","weight":-0.4556},{"period":"ytd","weight":-0.1007}],"compareEarnings":[{"period":"1week","weight":0.0149},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.0409},{"period":"6month","weight":0.0999},{"period":"1year","weight":0.2145},{"period":"ytd","weight":0.0403}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"硕迪生物公司于2019年2月在开曼群岛成立,在美国和中国设有运营子公司。该公司是一家临床阶段的全球生物制药公司,旨在开发和提供新型口服疗法,以治疗各种慢性疾病,满足医疗需求。公司的差异化技术平台利用基于结构的药物发现和计算化学专业知识,使公司能够开发口服小分子疗法,用于治疗各种疾病,包括影响代谢、心血管和肺系统的疾病。","exchange":"NASDAQ","name":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","nameEN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD,GPCR,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票老虎,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票老虎国际,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD行情,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票行情,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股价,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股市,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票价格,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票交易,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票购买,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}